Abstract
BIOCHEMICAL AND INFLAMMATORY BIOMARKERS ABNORMALITY ASSOCIATED WITH MORTALITY IN COVID-19- A RETROSPECTIVE OBSERVATIONAL STUDY IN A TERTIARY CARE CENTRE IN INDIA

Dr. Prakriti Gupta, Dr. Reema Kapoor Mehra ? and Dr. Navpreet Singh

ABSTRACT

Background and objectives: COVID 19 caused by SARS-CoV-2 virus was declared a pandemic by WHO on March 11, 2020. With primary involvement of the respiratory system, it causes ARDS, sepsis, septic shock, metabolic acidosis, coagulopathy, and multi-organ failure in case of severe infection leading to death. Thus comes the role of laboratory analysis of biochemical profile and immune biomarkers in disease management of COVID 19. Method It was a retrospective observational study which was conducted on data of 730 patients who were admitted with COVID 19 in Jayaarogya Hospital Gwalior. Baseline biomarkers were collected which included routine biochemical markers (RFT, LFT and electrolytes) and inflammatory parameters (IL-6, ferritin, Troponin I and procalcitonin). The data was collected and compared between deceased (n=97) and survivors (n=633). Result There was a significant increase in urea, creatinine and uric acid and AST in the deceased group along with significant hypoalbuminemia. All four inflammatory markers were significantly increased in the deceased group. Kaplan-Meier survival curves also showed that patients with IL-6, Troponin-I, or procalcitonin higher than the normal values had a significantly higher probability of mortality (log-rank, P < 0.05). The multivariate Cox model showed that Troponin-I (P = 0.028) could be used as independent factors to predict mortality. Conclusion Laboratory analysis of biochemical profile and immune biomarkers in patients infected with SARS-CoV-2 not only plays a role in monitoring treatment for better patient management in COVID 19 but also in prediction of disease severity and mortality.

Keywords: Biochemical profile, COVID 19, inflammatory markers, Mortality.


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tangudu Nagabhusana Rao

Download Article : Click here

News & Updation

  • EJBPS: SEPTEMBER ISSUE PUBLISHED

    SEPTEMBER 2021 Issue has been successfully launched on 1 September 2021

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT